A fibrin patch loaded with mesenchymal stem cells-derived exosomes improves cardiac functions after myocardial infarction
Source abstract
Abstract
Myocardial infarction (MI) is a typical cardiovascular disease, causing disability and death worldwide. Exosomes secreted by mesenchymal stem cells (MSCs) showed remarkable therapeutic effects in MI by restoring cardiac function. However, the application of exosomes remains a challenge because of their low residence rate in the infarcted myocardium. Herein, a fibrin-based cardiac patch was prepared to deliver MSCs-derived exosomes to the infarcted heart using an MI mouse model, aiming at improvement of cardiac functions. The fibrin patch was optimized for size to minimize the mouse mortality rate. The composite patch showed sustained release of exosomes in vitro and could improve the retention of exosomes in the infarcted heart, inhibiting fibrosis and improving cardiac functions in vivo. Therefore, this combination of natural biomaterial-based cardiac patch and MSCs-derived exosomes may have a promising clinical translational potential for the MI treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Heart disease and stroke statistics-2023 update: a report from the American Heart Association10.1161/CIR.0000000000001123 ↗
2. Damluji · Circulation · 2021 · 144 · e1610.1161/CIR.0000000000000985 ↗
3. SYNTAX investigators, percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease10.1056/NEJMoa0804626 ↗
4. Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics10.1038/nrd.2017.106 ↗
5. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury10.1038/nm1618 ↗
6. Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction10.1038/s41467-019-11091-2 ↗
7. Intrapericardial hydrogel injection generates high cell retention and augments therapeutic effects of mesenchymal stem cells in myocardial infarction
8. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation10.1161/CIRCRESAHA.110.222703 ↗
9. Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR-125b10.1161/CIRCRESAHA.118.312758 ↗
10. CHART investigators, benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the congestive heart failure Cardiopoietic regenerative therapy (CHART-1) study10.1002/ejhf.898 ↗
11. Mesenchymal stromal/stem cell-derived extracellular vesicles in tissue repair: challenges and opportunities10.7150/thno.40122 ↗
12. Extracellular vesicles in cardiovascular disease: potential applications in diagnosis, prognosis, and epidemiology10.1161/CIRCRESAHA.117.310752 ↗
13. Engineered extracellular vesicles and their mimics in cardiovascular diseases10.1016/j.jconrel.2022.04.046 ↗
14. Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide10.7150/thno.20524 ↗
15. Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine10.1126/scitranslmed.aay1318 ↗
16. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction
17. Microneedle patch loaded with exosomes containing MicroRNA-29b prevents cardiac fibrosis after myocardial infarction10.1002/adhm.202202959 ↗
18. Injectable decellularized extracellular matrix hydrogel loaded with exosomes encapsulating curcumin for prevention of cardiac fibrosis after myocardial infarction10.1016/j.jmst.2023.06.005 ↗
19. Biomaterials based cardiac patches for the treatment of myocardial infarction10.1016/j.jmst.2021.03.062 ↗
20. Injectable decellularized extracellular matrix hydrogel containing stromal cell-derived factor 1 promotes transplanted cardiomyocyte engraftment and functional regeneration after myocardial infarction10.1021/acsami.2c16682 ↗
21. Release of VEGF and BMP9 from injectable alginate based composite hydrogel for treatment of myocardial infarction
22. An injectable alginate/fibrin hydrogel encapsulated with cardiomyocytes and VEGF for myocardial infarction treatment10.1016/j.jmst.2022.11.002 ↗
23. Lithography-based 3D printed hydrogels: from bioresin designing to biomedical application
24. Recent Fabrications and Applications of Cardiac Patch in Myocardial Infarction Treatment10.1002/VIW.20200153 ↗
25. Fibrin matrices as (injectable) biomaterials: formation, clinical use, and molecular engineering10.1002/mabi.201900283 ↗
26. TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial10.1016/j.ejcts.2009.04.057 ↗
27. Bjelović · J. Gastrointest. Surg. · 2018 · 22 · 193910.1007/s11605-018-3852-4 ↗
28. Large cardiac muscle patches engineered from human induced-pluripotent stem cell–derived cardiac cells improve recovery from myocardial infarction in swine10.1161/CIRCULATIONAHA.117.030785 ↗
29. On-site fabrication of bi-layered adhesive mesenchymal stromal cell-dressings for the treatment of heart failure10.1016/j.biomaterials.2019.04.014 ↗
30. Functional consequences of a tissue-engineered myocardial patch for cardiac repair in a rat infarct model10.1089/ten.tea.2013.0312 ↗
31. Fibrin-based cardiac patch containing neuregulin-1 for heart repair after myocardial infarction10.1016/j.colsurfb.2022.112936 ↗
32. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells10.1016/j.stem.2014.11.009 ↗
33. A minimally invasive exosome spray repairs heart after myocardial infarction10.1021/acsnano.1c00628 ↗
34. Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhances myocardial repair10.1161/JAHA.115.002856 ↗
35. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies10.1111/j.1423-0410.2008.01076.x ↗
36. An optimal gel patch for the injured heart,10.1038/s41551-019-0440-1 ↗
37. Multifunctional elastomer cardiac patches for preventing left ventricle remodeling after myocardial infarction in vivo10.1016/j.biomaterials.2022.121382 ↗
38. A viscoelastic adhesive epicardial patch for treating myocardial infarction10.1038/s41551-019-0380-9 ↗
39. Adult mouse epicardium modulates myocardial injury by secreting paracrine factors10.1172/JCI45529 ↗
40. Cardiac regeneration from activated epicardium10.1371/journal.pone.0044692 ↗